Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1839]
News [4199]
Articles [376]
Editorials [10]
Conferences [104]
elearning [29]
CDK4/6 inhibitor abemaciclib plus fulvestrant improves overall survival in HR...
Prof George Sledge - Stanford Health Care, Stanford, USA
CDK4/6 inhibitor abemaciclib plus fulvestrant improves overall survival in HR-positive/HER2-negative advanced breast cancer ( Prof George Sledge - Stanford Health Care, Stanford, USA )
29 Sep 2019
Comment: CDK4/6 inhibitors in advanced breast cancer
Prof Nadia Harbeck - University of Munich, Munich, Germany
Comment: CDK4/6 inhibitors in advanced breast cancer ( Prof Nadia Harbeck - University of Munich, Munich, Germany )
29 Sep 2019
Immunotherapy added to chemotherapy improves pathological complete response in...
Prof Peter Schmid - St Bartholomew's Hospital London, London, UK
Immunotherapy added to chemotherapy improves pathological complete response in early triple negative breast cancer ( Prof Peter Schmid - St Bartholomew's Hospital London, London, UK )
29 Sep 2019
Important developments in radiation oncology
Dr Ana Botero - Memorial Healthcare System, Hollywood, FL, USA
Important developments in radiation oncology ( Dr Ana Botero - Memorial Healthcare System, Hollywood, FL, USA )
26 Jul 2019
Latest updates in HER2-positive metastatic breast cancer: The NALA and SOPHIA...
Dr Connie Guaqueta - Memorial Cancer Institute, Miami, USA
Latest updates in HER2-positive metastatic breast cancer: The NALA and SOPHIA trials ( Dr Connie Guaqueta - Memorial Cancer Institute, Miami, USA )
26 Jul 2019
Implementing the Breast Health Global Initiative guidelines
Prof Benjamin Anderson
Implementing the Breast Health Global Initiative guidelines ( Prof Benjamin Anderson )
12 Jul 2019
Guidelines for prepectoral implant-based breast reconstruction
Dr Raghavan Vidya - Royal Wolverhampton Hospital, Wolverhampton, UK
Guidelines for prepectoral implant-based breast reconstruction ( Dr Raghavan Vidya - Royal Wolverhampton Hospital, Wolverhampton, UK )
11 Jul 2019
CDK4/6 inhibitors in hormone receptor-positive, HER2-negative metastatic breast...
Dr Hikmat Abdel-Razeq - King Hussein Cancer Center, Amman, Jordan
CDK4/6 inhibitors in hormone receptor-positive, HER2-negative metastatic breast cancer ( Dr Hikmat Abdel-Razeq - King Hussein Cancer Center, Amman, Jordan )
10 Jul 2019
Implementing national cancer control plans
Dr Eduardo Cazap and Dr Lisa Stevens
Implementing national cancer control plans ( Dr Eduardo Cazap and Dr Lisa Stevens )
24 Jun 2019
PARP inhibitors olaparib and talazoparib as treatment for metastatic breast...
Dr Matteo Lambertini - San Martino Hospital, Genoa, Italy
PARP inhibitors olaparib and talazoparib as treatment for metastatic breast cancer ( Dr Matteo Lambertini - San Martino Hospital, Genoa, Italy )
18 Jun 2019
The potential of PARP inhibitors in new cancer groups and in combination with...
Dr Jennifer Litton - The University of Texas MD Anderson Cancer Center, Houston...
The potential of PARP inhibitors in new cancer groups and in combination with other treatments ( Dr Jennifer Litton - The University of Texas MD Anderson Cancer Center, Houston, USA )
18 Jun 2019
BYLieve study results: Alpelisib and endocrine therapy in patients with PIK3CA...
Prof Hope Rugo - University of California, San Francisco, USA
BYLieve study results: Alpelisib and endocrine therapy in patients with PIK3CA-mutated/HR /HER2- advanced breast cancer ( Prof Hope Rugo - University of California, San Francisco, USA )
12 Jun 2019

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation